Medtronic plc — Director's Dealing 2018

Aug 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-08-23

Reporting Person: POZEN ROBERT C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Ordinary Shares	M	2671	$29.96	Acquired	62369	Direct
2018-08-23	Ordinary Shares	M	1813	$44.13	Acquired	64182	Direct
2018-08-23	Ordinary Shares	S	3218	$95.941	Disposed	60964	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-23	Stock Option (Right to Buy)	$29.96	M	2671	Disposed	2019-04-27	Ordinary Shares (2671)	Direct
2018-08-23	Stock Option (Right to Buy)	$44.13	M	1813	Disposed	2020-05-03	Ordinary Shares (1813)	Direct

Footnotes

F1: This balance increased 155 shares due to exempt transactions such as dividend reinvestment.

F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F3: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.